In vivo effects of calcitriol on phenotypic and functional properties of Dendritic cells

Iranian Journal of Immunology

Volumn 7, Issue 2, 2010, Pages 74-82

  Eftekharian, Mohammad Mahdi ^a   Zarnani, Amir Hassan ^b,c   Moazzeni, Seyed Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholecalciferol; Dendritic cells; Immunomodulation; Vitamin D3

Indexed keywords

CALCITRIOL; CD11B ANTIGEN; CD86 ANTIGEN; CELL MARKER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOMODULATION; IN VIVO STUDY; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; FEMALE; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; MIXED LYMPHOCYTE CULTURE; PATHOLOGY; TH2 CELL;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD86; CALCITRIOL; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INJECTIONS, INTRAPERITONEAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED C57BL; SPLEEN; TH2 CELLS;

EID: 79952278138     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jacobs B, Wuttke M, Papewalis C, Seissler J, Schott M. Dendritic Cell Subtypes and In Vitro Generation of Dendritic Cells. Horm Metab Res. 2008; 40:99-107.
2. Merad M, Manz M G. Dendritic cell homeostasis. Blood. 2009; 113:3418-27.
3. Onji M, Akbar SMF. Dendritic Cells in Clinics. 2nd ed. Japan: Springer; 2008.
4. Jung S. Good, bad and beautiful-the role of dendritic cells in autoimmunity. Autoimmun Rev. 2004; 3:45-60.
5. Dakic A, Wu L. Hemopoietic precursors and development of dendritic cell populations. Leuk Lymphoma. 2003; 44: 1469-75.
6. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002; 2: 151-61.
7. Hochrein H, O'keeffe M, Wagner H. Human and mouse plasmacytoid dendritic cells. Hum Immunol. 2002; 63:1103-10.
8. Ardavin C. Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol. 2003; 3:582-90.
9. Berer A, Stockl J, Majdic O, Wagner T, Kollars M, Lechner K, et al. 1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol. 2000; 28:575-83.
10. Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood. 1993; 82:1300-7.
11. Penna G, Adorini L. 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000; 164:2405-11.
12. Van Etten E, Mathieu C. Immunoregulation by 1, 25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol. 2005; 97:93-101.
13. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998; 13:325-49.
14. Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC, et al. Dendritic cells as key targets for immuno-modulation by vitamin D receptor ligands. J Ster Biochem Mol Biol. 2004; 89-90:437-41.
15. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol. 2002; 2:1017-28.
16. Griffin MD, Kumar R. Effects of 1α,25(OH)2D3 and its analogs on dendritic cell function. J Cell Biochem. 2003; 88:323-26.
17. Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med. 2002; 8:174-9.
18. Enioutina EY, Bareyan D, Daynes RA. Vitamin D3-mediated alteration to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Vaccine. 2007; 25:1236-49.
19. Adorini L, Giarratana N, Penna G. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol. 2004; 16:127-34.
20. Muthian G, Raikwar HP, Rajasingh J, Bright JJ. 1,25-Dihydroxyvitamin D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res. 2006; 83:1299-309.
21. Lemire JM, Archer DC. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991; 87:1103-7.
22. Zarnani AH, Moazzeni SM, Shokri F, Salehnia M, Dokouhaki P, Shojaeian J, et al. The efficient isolation of murine splenic dendritic cells and their cytochemical features. Histochem Cell Biol. 2006; 126:275-82.
23. Shimazaki M, Miyamoto Y, Yamamoto K, Yamada S, Takami M, Shinki T, et al. Analogs of 1α,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: Synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs. Bioorgan Med Chem. 2006; 14:4645-56.
24. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. 2000; 164:4443-51.
25. Van Halteren AGS, Van Etten E, De Jong EC, Bouillon R, Roep BO, Mathieu C. Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D3. Diabetes. 2002; 51:2119-25.
26. Gauzzi MC, Purificato C, Donato K, Jin Y, Wang L, Daniel KC, et al. Suppressive effect of 1α,25-didydroxyvitamin D3 on type I IFN-Mediated monocyte differentiation into dendritic cells: Impairment of functional activities and chemotaxis. J Immunol. 2005; 174:270-6.
27. Pedersen AE, Gad M, Walter MR, Claesson MH. Induction of regulatory dendritic cells by dexamethasone and 1α,25-dihydroxyvitamin D3. Immunol Lett. 2004; 91:63-9.
28. VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr. 2004; 58:1095-109.
29. Szeles L, Keresztes G, Torocsik D, Balajthy Z, Krenacs L, Poliska S, et al. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol. 2009; 182:2074-83.
30. Gauzzi MC, Purificato C, Conti L, Adorini L, Belardelli F, Gessani S. IRF-4 expression in the human myeloid lineage: up-regulation during dendritic cell differentiation and inhibition by 1α,25-dihydroxyvitamin D3. J Leukoc Biol. 2005; 77:944-7.
31. Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+ Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood. 2005; 106.:3490-7.
32. Griffin MD, Lutz W, Phan Vy A, Bachman LA, Mckean DJ, Kumar R. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a prsistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A. 2001; 98:6800-5.
33. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by1{alpha},25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance. J Immunol. 2001; 167:1945-53.
34. Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol. 2007; 178:145-53.